Luca Bordoni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Luca Bordoni has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Donato Sardella
Department of Biomedicine, Aarhus University, Aarhus, Denmark
3 shared publications - Sebastian Frische
Department of Biomedicine, Aarhus University, Aarhus, Denmark
3 shared publications - Anders Meldgaard Kristensen
Department of Biomedicine, Aarhus University, Aarhus, Denmark
2 shared publications - Eugenio Gutiérrez-Jiménez
Aarhus University
2 shared publications Hanne Kidmose
Department of Biomedicine, Aarhus University, Aarhus, Denmark
2 shared publications- Ina Maria Schiessl
Department of Biomedicine, Aarhus University, Aarhus, Denmark
2 shared publications
Latest Publications
- Open Access
- 24 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (43) , eadz5358
In vivo expression of VCAM1 precedes nephron loss following kidney tubular necrosis
Nephron loss is a key event during onset and progression of chronic kidney disease, yet the mechanisms dictating tubule repair versus atrophy remain poorly understood. While fibrosis has been proposed to drive progressive organ damage, antifibrotic therapies have failed in clinical trials. Here, we reveal that tubular vascular cell adhesion molecule 1 (VCAM1) expression precedes nephron loss, fibrosis, and long-term kidney dysfunction. Using serial intravital microscopy in transgenic mice, we track tubulointerstitial remodeling between injured and intact tissue over 3 weeks. VCAM1 is rapidly induced in a distinct subset of injured tubules, preceding atrophy with sustained fibroblast recruitment. However, fibroblasts remain confined to injury sites and do not cause secondary damage in uninjured tubules. Last, in human kidney transplant biopsies, tubular VCAM1 expression, but not kidney injury molecule 1, correlates negatively with early and 12-month graft function, underscoring its potential as a biomarker of adverse outcomes. These findings position VCAM1 as an early indicator of tubular fate and nephron loss.
- 24 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (43) , eadz5358
Open AccessIn vivo expression of VCAM1 precedes nephron loss following kidney tubular necrosis
Nephron loss is a key event during onset and progression of chronic kidney disease, yet the mechanisms dictating tubule repair versus atrophy remain poorly understood. While fibrosis has been proposed to drive progressive organ damage, antifibrotic therapies have failed in clinical trials. Here, we reveal that tubular vascular cell adhesion molecule 1 (VCAM1) expression precedes nephron loss, fibrosis, and long-term kidney dysfunction. Using serial intravital microscopy in transgenic mice, we track tubulointerstitial remodeling between injured and intact tissue over 3 weeks. VCAM1 is rapidly induced in a distinct subset of injured tubules, preceding atrophy with sustained fibroblast recruitment. However, fibroblasts remain confined to injury sites and do not cause secondary damage in uninjured tubules. Last, in human kidney transplant biopsies, tubular VCAM1 expression, but not kidney injury molecule 1, correlates negatively with early and 12-month graft function, underscoring its potential as a biomarker of adverse outcomes. These findings position VCAM1 as an early indicator of tubular fate and nephron loss.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S21)
Effect of long‐term treatment with carbonic anhydrase inhibitors on the brain microcirculation in Tg‐SwDI mice
Background: Alzheimer’s disease (AD) shares many risk factors with cardiovascular diseases, and much evidence shows that AD involves a cerebrovascular component. AD patients display disturbances in brain hemodynamics characterized by decreased cerebral blood flow (CBF) during steady‐state conditions. It has been suggested that capillary stalls heavily impact the CBF of AD animal models. Increased stalling time may impair capillary flow patterns, reducing oxygen availability to the brain tissue. Previous studies have shown that capillary stalling is induced by leukocyte plugging due to damage to the capillary endothelium and adhesion molecules' expression. Carbonic anhydrase inhibitors (CAIs), potent vasodilators, have been shown to reduce amyloid β (Aβ) neurovascular toxicity. We examined capillary hemodynamics in the Tg‐SwDI mouse model after long‐term treatment with CAIs.Method: Four months old Tg‐SwDI mice were fed for 140 – 150 days with a diet supplemented with acetazolamide (ATZ), methazolamide (MTZ), or no medication (Tg‐Ctrl). A control group of wild‐type (WT) mice was also included. We performed imaging in awake head‐restrained Tg‐SwDI and WT mice through a cranial window placed onto the barrel cortex’s somatosensory area. Capillary stalls were quantified using time‐series OCT‐angiography. We examined capillary hemodynamics, morphometrics, and amyloid load using two‐photon microscopy. The distribution of flow dynamics was estimated as the coefficient of variance (CVs) of capillary scans. Amyloid load and ICAM‐1 expression were measured in the brain cortex and hippocampus using ELISA.Result: We included 62 mice (mean 16 ± 3 per group). Both treated groups showed a decreased stalling time compared to the Tg‐Ctrl group (p < 0.05). Mice treated with MTZ showed larger capillary diameters correlated to increased cell flux and velocity (p ≤ 0.01). We observed a similar in mice treated with ATZ. Cell velocity and diameter CVs were much smaller in mice treated with ATZ than in non‐treated mice (p < 0.01), indicating more homogenous capillary flow patterns. We observed a similar tendency in the MTZ group. Hemodynamic changes were associated with decreased Ab‐42 and ICAM‐1.Conclusion: Treatment with CAIs improves capillary flow hemodynamics and distribution, preventing amyloid accumulation in brain tissue. Improvement of capillary flow patterns is associated with better oxygen diffusion.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S21)
Open AccessEffect of long‐term treatment with carbonic anhydrase inhibitors on the brain microcirculation in Tg‐SwDI mice
Background: Alzheimer’s disease (AD) shares many risk factors with cardiovascular diseases, and much evidence shows that AD involves a cerebrovascular component. AD patients display disturbances in brain hemodynamics characterized by decreased cerebral blood flow (CBF) during steady‐state conditions. It has been suggested that capillary stalls heavily impact the CBF of AD animal models. Increased stalling time may impair capillary flow patterns, reducing oxygen availability to the brain tissue. Previous studies have shown that capillary stalling is induced by leukocyte plugging due to damage to the capillary endothelium and adhesion molecules' expression. Carbonic anhydrase inhibitors (CAIs), potent vasodilators, have been shown to reduce amyloid β (Aβ) neurovascular toxicity. We examined capillary hemodynamics in the Tg‐SwDI mouse model after long‐term treatment with CAIs.Method: Four months old Tg‐SwDI mice were fed for 140 – 150 days with a diet supplemented with acetazolamide (ATZ), methazolamide (MTZ), or no medication (Tg‐Ctrl). A control group of wild‐type (WT) mice was also included. We performed imaging in awake head‐restrained Tg‐SwDI and WT mice through a cranial window placed onto the barrel cortex’s somatosensory area. Capillary stalls were quantified using time‐series OCT‐angiography. We examined capillary hemodynamics, morphometrics, and amyloid load using two‐photon microscopy. The distribution of flow dynamics was estimated as the coefficient of variance (CVs) of capillary scans. Amyloid load and ICAM‐1 expression were measured in the brain cortex and hippocampus using ELISA.Result: We included 62 mice (mean 16 ± 3 per group). Both treated groups showed a decreased stalling time compared to the Tg‐Ctrl group (p < 0.05). Mice treated with MTZ showed larger capillary diameters correlated to increased cell flux and velocity (p ≤ 0.01). We observed a similar in mice treated with ATZ. Cell velocity and diameter CVs were much smaller in mice treated with ATZ than in non‐treated mice (p < 0.01), indicating more homogenous capillary flow patterns. We observed a similar tendency in the MTZ group. Hemodynamic changes were associated with decreased Ab‐42 and ICAM‐1.Conclusion: Treatment with CAIs improves capillary flow hemodynamics and distribution, preventing amyloid accumulation in brain tissue. Improvement of capillary flow patterns is associated with better oxygen diffusion.
- Open Access
- 21 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-18
Longitudinal tracking of acute kidney injury reveals injury propagation along the nephron
Acute kidney injury (AKI) is an important risk factor for chronic kidney disease (CKD), but the underlying mechanisms of failed tubule repair and AKI-CKD transition are incompletely understood. In this study, we aimed for dynamic tracking of tubule injury and remodeling to understand if focal injury upon AKI may spread over time. Here, we present a model of AKI, in which we rendered only half of the kidney ischemic. Using serial intravital 2-photon microscopy and genetic identification of cycling cells, we tracked dynamic tissue remodeling in post- and non-ischemic kidney regions simultaneously and over 3 weeks. Spatial and temporal analysis of cycling cells relative to initial necrotic cell death demonstrated pronounced injury propagation and expansion into non-necrotic tissue regions, which predicted tubule atrophy with epithelial VCAM1 expression. In summary, our longitudinal analyses of tubule injury, remodeling, and fate provide important insights into AKI pathology.
- 21 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-18
Open AccessLongitudinal tracking of acute kidney injury reveals injury propagation along the nephron
Acute kidney injury (AKI) is an important risk factor for chronic kidney disease (CKD), but the underlying mechanisms of failed tubule repair and AKI-CKD transition are incompletely understood. In this study, we aimed for dynamic tracking of tubule injury and remodeling to understand if focal injury upon AKI may spread over time. Here, we present a model of AKI, in which we rendered only half of the kidney ischemic. Using serial intravital 2-photon microscopy and genetic identification of cycling cells, we tracked dynamic tissue remodeling in post- and non-ischemic kidney regions simultaneously and over 3 weeks. Spatial and temporal analysis of cycling cells relative to initial necrotic cell death demonstrated pronounced injury propagation and expansion into non-necrotic tissue regions, which predicted tubule atrophy with epithelial VCAM1 expression. In summary, our longitudinal analyses of tubule injury, remodeling, and fate provide important insights into AKI pathology.
- Open Access
Deletion of aquaporin‐4 improves capillary blood flow distribution in brain edema
Brain edema is a feared complication to disorders and insults affecting the brain. It can be fatal if the increase in intracranial pressure is sufficiently large to cause brain herniation. Moreover, accruing evidence suggests that even slight elevations of intracranial pressure have adverse effects, for instance on brain perfusion. The water channel aquaporin‐4 (AQP4), densely expressed in perivascular astrocytic endfeet, plays a key role in brain edema formation. Using two‐photon microscopy, we have studied AQP4‐mediated swelling of astrocytes affects capillary blood flow and intracranial pressure (ICP) in unanesthetized mice using a mild brain edema model. We found improved regulation of capillary blood flow in mice devoid of AQP4, independently of the severity of ICP increase. Furthermore, we found brisk AQP4‐dependent astrocytic Ca2+ signals in perivascular endfeet during edema that may play a role in the perturbed capillary blood flow dynamics. The study suggests that astrocytic endfoot swelling and pathological signaling disrupts microvascular flow regulation during brain edema formation.
Open AccessDeletion of aquaporin‐4 improves capillary blood flow distribution in brain edema
Brain edema is a feared complication to disorders and insults affecting the brain. It can be fatal if the increase in intracranial pressure is sufficiently large to cause brain herniation. Moreover, accruing evidence suggests that even slight elevations of intracranial pressure have adverse effects, for instance on brain perfusion. The water channel aquaporin‐4 (AQP4), densely expressed in perivascular astrocytic endfeet, plays a key role in brain edema formation. Using two‐photon microscopy, we have studied AQP4‐mediated swelling of astrocytes affects capillary blood flow and intracranial pressure (ICP) in unanesthetized mice using a mild brain edema model. We found improved regulation of capillary blood flow in mice devoid of AQP4, independently of the severity of ICP increase. Furthermore, we found brisk AQP4‐dependent astrocytic Ca2+ signals in perivascular endfeet during edema that may play a role in the perturbed capillary blood flow dynamics. The study suggests that astrocytic endfoot swelling and pathological signaling disrupts microvascular flow regulation during brain edema formation.
- Open Access
- 1 January 2022
- Published by SAGE Publications in Molecular Imaging
- Vol. 2022, 7908357
The Probe for Renal Organic Cation Secretion (4-Dimethylaminostyryl)-N-Methylpyridinium (ASP+)) Shows Amplified Fluorescence by Binding to Albumin and Is Accumulated In Vivo
Accumulation of uremic toxins may lead to the life-threatening condition “uremic syndrome” in patients with advanced chronic kidney disease (CKD) requiring renal replacement therapy. Clinical evaluation of proximal tubular secretion of organic cations (OC), of which some are uremic toxins, is desired, but difficult. The biomedical knowledge on OC secretion and cellular transport partly relies on studies using the fluorescent tracer 4-dimethylaminostyryl)- N-methylpyridinium (ASP+), which has been used in many studies of renal excretion mechanisms of organic ions and which could be a candidate as a PET tracer. This study is aimed at expanding the knowledge of the tracer characteristics of ASP+ by recording the distribution and intensity of ASP+ signals in vivo both by fluorescence and by positron emission tomography (PET) imaging and at investigating if the fluorescence signal of ASP+ is influenced by the presence of albumin. Two-photon in vivo microscopy of male Münich Wistar Frömter rats showed that a bolus injection of ASP+ conferred a fluorescence signal to the blood plasma lasting for about 30 minutes. In the renal proximal tubule, the bolus resulted in a complex pattern of fluorescence including a rapid and strong transient signal at the brush border, a very low signal in the luminal fluid, and a slow transient intracellular signal. PET imaging using 11C-labelled ASP+ showed accumulation in the liver, heart, and kidney. Fluorescence emission spectra recorded in vitro of ASP+ alone and in the presence of albumin using both 1-photon excitation and two-photon excitation showed that albumin strongly enhance the emission from ASP+ and induce a shift of the emission maximum from 600 to 570 nm. Conclusion. The renal pattern of fluorescence observed from ASP+ in vivo is likely affected by the local concentration of albumin, and quantification of ASP+ fluorescent signals in vivo cannot be directly translated to ASP+ concentrations.
- 1 January 2022
- Published by SAGE Publications in Molecular Imaging
- Vol. 2022, 7908357
Open AccessThe Probe for Renal Organic Cation Secretion (4-Dimethylaminostyryl)-N-Methylpyridinium (ASP+)) Shows Amplified Fluorescence by Binding to Albumin and Is Accumulated In Vivo
Accumulation of uremic toxins may lead to the life-threatening condition “uremic syndrome” in patients with advanced chronic kidney disease (CKD) requiring renal replacement therapy. Clinical evaluation of proximal tubular secretion of organic cations (OC), of which some are uremic toxins, is desired, but difficult. The biomedical knowledge on OC secretion and cellular transport partly relies on studies using the fluorescent tracer 4-dimethylaminostyryl)- N-methylpyridinium (ASP+), which has been used in many studies of renal excretion mechanisms of organic ions and which could be a candidate as a PET tracer. This study is aimed at expanding the knowledge of the tracer characteristics of ASP+ by recording the distribution and intensity of ASP+ signals in vivo both by fluorescence and by positron emission tomography (PET) imaging and at investigating if the fluorescence signal of ASP+ is influenced by the presence of albumin. Two-photon in vivo microscopy of male Münich Wistar Frömter rats showed that a bolus injection of ASP+ conferred a fluorescence signal to the blood plasma lasting for about 30 minutes. In the renal proximal tubule, the bolus resulted in a complex pattern of fluorescence including a rapid and strong transient signal at the brush border, a very low signal in the luminal fluid, and a slow transient intracellular signal. PET imaging using 11C-labelled ASP+ showed accumulation in the liver, heart, and kidney. Fluorescence emission spectra recorded in vitro of ASP+ alone and in the presence of albumin using both 1-photon excitation and two-photon excitation showed that albumin strongly enhance the emission from ASP+ and induce a shift of the emission maximum from 600 to 570 nm. Conclusion. The renal pattern of fluorescence observed from ASP+ in vivo is likely affected by the local concentration of albumin, and quantification of ASP+ fluorescent signals in vivo cannot be directly translated to ASP+ concentrations.
- Open Access
- 1 January 2020
- Published by Japanese Association for Laboratory Animal Science in Experimental Animals
- Vol. 69 (1) , 92-103
A new experimental mouse model of water intoxication with sustained increased intracranial pressure and mild hyponatremia without side effects of antidiuretics
The most used experimental mouse model of hyponatremia and elevated intracranial pressure (ICP) is intraperitoneal injection of water in combination with antidiuretics. This model of water intoxication (WI) results in extreme pathological changes and death within 1 hr. To improve preclinical studies of the pathophysiology of elevated ICP, we characterized diuresis, cardiovascular parameters, blood ionogram and effects of antidiuretics in this model. We subsequently developed a new mouse model with mild hyponatremia and sustained increased ICP. To investigate the classical protocol (severe WI), C57BL/6mice were anesthetized and received an intraperitoneal injection of 20% body weight of MilliQ water with or without 0.4 µg·kg-1 desmopressin acetate (dDAVP). Corresponding Sham groups were also studied. In the new WI protocol (mild WI), 10% body weight of a solution containing 6.5 mM NaHCO3, 1.125 mM KCl and 29.75 mM NaCl was intraperitoneally injected. By severe WI, ICP and mean arterial pressure increased until brain stem herniation occurred (23 ± 3 min after injection). The cardiovascular effects were accelerated by dDAVP. Severe WI induced a halt to urine production irrespective of the use of dDAVP. Following the new mild WI protocol, ICP also increased but was sustained at a pathologically high level without inducing herniation. Mean arterial pressure and urine production were not affected during mild WI. In conclusion, the new mild WI protocol is a superior experimental model to study the pathophysiological effects of elevated ICP induced by water intoxication.
- 1 January 2020
- Published by Japanese Association for Laboratory Animal Science in Experimental Animals
- Vol. 69 (1) , 92-103
Open AccessA new experimental mouse model of water intoxication with sustained increased intracranial pressure and mild hyponatremia without side effects of antidiuretics
The most used experimental mouse model of hyponatremia and elevated intracranial pressure (ICP) is intraperitoneal injection of water in combination with antidiuretics. This model of water intoxication (WI) results in extreme pathological changes and death within 1 hr. To improve preclinical studies of the pathophysiology of elevated ICP, we characterized diuresis, cardiovascular parameters, blood ionogram and effects of antidiuretics in this model. We subsequently developed a new mouse model with mild hyponatremia and sustained increased ICP. To investigate the classical protocol (severe WI), C57BL/6mice were anesthetized and received an intraperitoneal injection of 20% body weight of MilliQ water with or without 0.4 µg·kg-1 desmopressin acetate (dDAVP). Corresponding Sham groups were also studied. In the new WI protocol (mild WI), 10% body weight of a solution containing 6.5 mM NaHCO3, 1.125 mM KCl and 29.75 mM NaCl was intraperitoneally injected. By severe WI, ICP and mean arterial pressure increased until brain stem herniation occurred (23 ± 3 min after injection). The cardiovascular effects were accelerated by dDAVP. Severe WI induced a halt to urine production irrespective of the use of dDAVP. Following the new mild WI protocol, ICP also increased but was sustained at a pathologically high level without inducing herniation. Mean arterial pressure and urine production were not affected during mild WI. In conclusion, the new mild WI protocol is a superior experimental model to study the pathophysiological effects of elevated ICP induced by water intoxication.